Marijuana Enforcement Division 2023 Regulatory Agenda Report
Rule Number | Rule Title | New rule, | Statutory or | Purpose | Stakeholders | Status | Adoption Date | Comments |
---|---|---|---|---|---|---|---|---|
1 CCR 212-3 Rule 2-205 | Fees | Revision | 44-10-103, 44-10-202(1)(b), 44- 10-202(1)(c), 44-10-202(1)(e), 44- 10-203(1)(k), 44-10-203(1)(i), 44- 10-203(2)(b), 44-10-203(2)(h), 44- 10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303 (2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10- 1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a) (II). | Revision | MED Stakeholder list | Ongoing | July 1, 2023 | |
1 CCR 212-3 Rule 3-1100 Series | Accelerator Program Operations | Revision | 44-10-202(1)(c), 44-10- 203(2) (aa), 44-10-310(2), and 44-10-311 (2), C.R.S. | Review | MED Stakeholder list | Ongoing | January 8, 2024 | |
1 CCR 212-3, Rule 3-315 | Independent Health and Safety Audit | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(1)(g), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), and 44-10-1001 (2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a) (VII) | Review | MED Stakeholder list | Ongoing | January 8, 2024 | |
MED Stakeholder List: | The standard MED stakeholder list includes Licensees, Division listserv subscribers, local licensing authorities, local law enforcement, healthcare providers, researchers, public safety advocates, Colorado Department of Agriculture, Colorado Department of Public Health and Environment, and the general public. |
Schedule (MO/YR) | Rule Number | Rule Title | Statutory or | Did review result in revisions to regulation? | Did review result in repeal of any part of the regulation? If so, how many rules? | Did review result in repeal of entire CCR volume? | Adoption Date | Comments |
---|---|---|---|---|---|---|---|---|
August 2023 | 1 CCR 212-3, Rule 4-110 | Regulated Marijuana Testing Program: Mandatory Testing | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Yes | No | No | January 8, 2024 | |
August 2023 | 1 CCR 212-3, Rule 4-120 | Regulated Marijuana Testing Program: Contaminant Testing | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Yes | No | No | January 8, 2024 | |
August 2023 | 1 CCR 212-3, Rule 4-121 | Regulated Marijuana Testing Program: Wet Whole Plant Contaminant Testing | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Yes | No | No | January 8, 2024 | |
August 2023 | 1 CCR 212-3, Rule 4-125 | Regulated Marijuana Testing Program: Potency Testing | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Yes | No | No | January 8, 2024 |
Rule Number | Rule Title | New rule, | Statutory or | Purpose | Stakeholders | Status | Adoption Date | Comments |
---|---|---|---|---|---|---|---|---|
1 CCR 212-3 Rule 1-115 | Definitions | Revision | 44-10-202(1)(c), 44-10-202(1)(j), and 44-10-103, C.R.S. | Added the following definitions: “Genetic Material”, "Hemp", "Hemp Product", "Intoxicating Cannabinoid", "Microbial Control Step", "Notice of Destruction", "Notice of Embargo", "Safe Harbor Hemp Product", "Sample Plan", "Semi-synthetic Cannabinoid", "Social Equity Business", and "Synthetic Cannabinoid". Clarified the following definitions: "Adverse Health Event" to include an "unexpected" health condition. "Decontamination" to indicate "following a failed test". "Employee License" to remove references to Key Licenses and Support Licenses. "Remediation" to indicate "following a failed test". Removed the following definitions: "Industrial Hemp" and "Industrial Hemp Product" | MED Stakeholder List | Adopted | January 8, 2023 | |
1 CCR 212-3 Rule 2-206 | Social Equity Fees | New | 44-10-103, 44-10-202(1)(b), 44- 10-202(1)(c), 44-10-202(1)(e), 44- 10-203(1)(k), 44-10-203(1)(i), 44- 10-203(2)(b), 44-10-203(2)(h), 44- 10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303 (2)(b), 44-10-308(5); 44-10-310 (7), 44-10-313, 44-10-401, 44-10- 801, 44-10-802, 44-10-803, 44-10- 1201, 44-10-1202, C.R.S | Establishes a separate fee section for Social Equity Licenses and applications. | MED Stakeholder List | Adopted | July 1, 2023 | |
1 CCR 212-3 Rule 2-220 (B)(2)(b) | Initial Application Requirements for Regulated Marijuana Businesses | Revision | 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(c), 44-10-203(1)(j), 44-10-203(1)(k), 44-10-203(2)(a), 44-10-203(2)(w), 44-10-203(2) (ee), 44-10-203(7), 44-10-301, 44- 10-305, 44-10-307, 44-10-308, 44- 10-309, 44-10-310, 44-10-311, 44- 10- 312, 44-10-313, and 44-10- 316, C.R.S. | Rule was changed to implement SB 23-199 - State license may be renewed if local approval has not been obtained within one year with good cause. | MED Stakeholder List | Adopted | August 8, 2023 | |
1 CCR 212-3 Rule 2-220 (C)(3)(a) | Initial Application Requirements for Regulated Marijuana Businesses | Revision | 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(c), 44-10-203(1)(j), 44-10-203(1)(k), 44-10-203(2)(a), 44-10-203(2)(w), 44-10-203(2) (ee), 44-10-203(7), 44-10-301, 44- 10-305, 44-10-307, 44-10-308, 44- 10-309, 44-10-310, 44-10-311, 44- 10- 312, 44-10-313, and 44-10- 316, C.R.S. | Language in the rule was updated to provide clarification of the rule. | MED Stakeholder List | Adopted | August 8, 2023 | |
1 CCR 212-3 Rule 2-225 (A) | Renewal Application Requirements for All Licenses | Revision | 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(c), 44-10-203(2)(a), 44-10-203(2)(c), 44-10-203(2)(w), 44-10-203(2)(ee), 44-10-203(7), 44-10-305(2)(b)(i)(C), 44- 10-307, 44-10-308, 44-10-309, 44-10-313, 44-10-314, and 44-10-316, C.R.S. | Adds clarity by including a period not to exceed. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 2-225 (G)(2)(a) | Renewal Application Requirements for All Licenses | Revision | 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(c), 44-10-203(2)(a), 44-10-203(2)(c), 44-10-203(2)(w), 44-10-203(2)(ee), 44-10-203(7), 44-10-305(2)(b)(i)(C), 44- 10-307, 44-10-308, 44-10-309, 44-10-313, 44-10-314, and 44-10-316, C.R.S. | Rule was changed to implement SB 23-199 - State license may be renewed if local approval has not been obtained within one year with good cause. | MED Stakeholder List | Ongoing | August 8, 2023 | |
1 CCR 212-3 Rule 2-235 (A)(2) | Suitability | Revision | 44-10-202(1)(e), 44-10-203(2)(c), 44-10-203(2)(ee), 44-10-309, 44- 10-310, and 44-10-312(4), C.R.S. | Changes Entity to Regulated Marijuana Business for clarity. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 2-235 (H) | Suitability | Revision | 44-10-202(1)(e), 44-10-203(2)(c), 44-10-203(2)(ee), 44-10-309, 44- 10-310, and 44-10-312(4), C.R.S. | Adds clarity by including upon approval and issuance of an Owner License, a finding of suitability is no longer valid. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 2-245 (D)(2) | Change of Controlling Beneficial Owner Application or Notification | Revision | 44-10-202(1)(e), 44-10-203(1)(d), 44-10-203(1)(k), 44-10-203(2)(ee) (I)(A) and (E), 44-10-203(7), 44- 10-308(3)(b), 44-10-309, 44-10- 310, 44-10-311, 44-10-312, 44-10- 505(1)(a), and 44-10-605(1)(a), C.R.S. | Added three days to the established thirty day timeline to allow for time to complete processing of applications. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 2-275 (A)(2) | Temporary Appointee Registrations for Court Appointees | Revision | 44-10-202(1)(b)-(c), 44-10-203(1) (k), 44-10-203(2)(q), 44-10-203(2) (t), 11-10-310, 44-10-401(3)(a)- (d), C.R.S. | Added clarity to the rule by including change of ownership. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-110 (C) | Regulated Marijuana Businesses: General Restrictions | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-401(2), 44-10-701(1)(a), 44- 10-701(3)(d), and 44-10-701(3)(f), C.R.S. | Revised to prohibit Natural Medicine. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-110 (D) | Regulated Marijuana Businesses: General Restrictions | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-401(2), 44-10-701(1)(a), 44- 10-701(3)(d), and 44-10-701(3)(f), C.R.S. | Revised to add Safe Harbor Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-225 (B)(4) | Video Surveillance | Revision | 44-10-203(2)(h), 44-10-203(1)(k), 44-10-203(2)(e), 44-10-313(14), and 44-10-1001, C.R.S. | Revised rule to shorten time requirement for battery backup. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-225 (E) | Video Surveillance | Revision | 44-10-203(2)(h), 44-10-203(1)(k), 44-10-203(2)(e), 44-10-313(14), and 44-10-1001, C.R.S. | Revised rule to shorten time requirement for all surveillance records. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-305 | Local Safety Inspections | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(3)(f), and 44-10-1001 (2), C.R.S. | Changed rule to inspect for compliance with local health and safety regulations for clarity. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-320 | Contaminated Product | Revision | 44-10-202(1)(c),44-10-203(1)(k), 44-10-203(2)(e), and 29-2-114(8) (a), C.R.S. | Added approved Decontamination and Microbial Control Step Methods. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-325 (A) | Prohibited Chemicals | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(dd) (X), and 44-10-203(3)(c), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Added Medical Marijuana Products Manufacturer, Retail Marijuana Products Manufacturer and Accelerator Manufacturer licenses to the rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-325 (B) | Prohibited Chemicals | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(dd) (X), and 44-10-203(3)(c), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Clarified the production of a Regulated Marijuana and added Regulated Marijuana Product or Industrial Hemp Product to the rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-330 (D)(1)(b) | Cultivation of Regulated Marijuana: Specific Health and Safety Requirements | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(dd) (X), and 44-10-203(3)(c), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Added Microbial Control Steps processes and documentation requirements. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-330 (D)(1)(e) | Cultivation of Regulated Marijuana: Specific Health and Safety Requirements | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-203(3)(c), 44-10-203(3)(e), and 44-10-1001, C.R.S. | Added RTA for microbial contaminant testing requirements. | MED Stakeholder List | Ongoing | July 1, 2024 | Effective date in the rules, July 1, 2024. |
1 CCR 212-3 Rule 3-330 (D)(5)(h) | Cultivation of Regulated Marijuana: Specific Health and Safety Requirements | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-203(3)(c), 44-10-203(3)(e), and 44-10-1001, C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-335 (G.5) | Production of Regulated Marijuana Concentrate and Regulated Marijuana Products: Specific Health and Safety Requirements | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-202(2)(y), 44- 10-203(3)(b), 44-10-203(3)(c), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-203(3)(g), and 44-10-1001, C.R.S. | Implements SB 23-271 with an initial allowance to help promote research into appropriate processes for semi-synthetic and synthetic cannabinoid production. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-336 (D)(4)(d)(i)(D) | Recall of Regulated Marijuana | Revision | 44-10-202(1)(b)-(c), 44-10-203(1) (k), 44-10-203(2)(d)(l)-(VI), 44-10- 203(2)(m), 44-10-401(2)(a)(III), 44-10-503, and 44-10-901(1), C.R. S. | Replaced estimated time frame with approximate time required to complete the recall. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-605 (G)(3) | Transport and Storage | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(n), 44-10-203(3)(c), 44-10-313(5)(b), 44-10-505, and 44-10-605 C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-605 (I)(2)(b) | Transport and Storage | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(n), 44-10-203(3)(c), 44-10-313(5)(b), 44-10-505, and 44-10-605 C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-610 (E)(1) | Off-Premises Storage of Regulated Marijuana: All Regulated Marijuana Businesses | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(n), 44-10-313(14), 44-10-505(2), 44-10-605(2), and 44-10-1001(2), C.R.S. | Added Accelerator Store to the rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-615 (A)(5)(b) | Regulated Marijuana Delivery Permits | Revision | 44-10-202(1), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(h), 44- 10-203(2)(n), 44-10-203(2)(dd), C.R.S. | Clarified rule by including a period not to exceed. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-615 (E)(6) | Regulated Marijuana Delivery Permits | Revision | 44-10-202(1), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(h), 44- 10-203(2)(n), 44-10-203(2)(dd), C.R.S. | Revised rule to shorten time requirement for all surveillance records. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-705 | Advertising General Requirements | Revision | 44-10-202(1)(c), 44-10-203(3)(a), and 44-10-701(3)(c), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VIII). | Clarified rule to add Health or Physical Benefit Claims Prohibited. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-805 Basis and Purpose | Inventory Tracking Requirements | Revision | 44-10-201(1), 44-10-202(1)(a), 44- 10-203(1)(c), 44-10-203(1)(k), 44- 10-203(2)(h), 44-10-501(1)(b), 44- 10-502(2), 44-10-503(1)(b), 44- 10-505(3), 44-10-601(1)(d), 44-10- 602(3), 44-10-603(1)(b), 44-10- 605(3), and 44-10-610(3)(a), C.R.S. | Clarified rule to allow for the reevaluating the benefits of and alternatives to certain aspects of the current Inventory Tracking System such as RFID technology requirements. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-805 (D) | Regulated Marijuana Businesses: Inventory Tracking System | Revision | 44-10-201(1), 44-10-202(1)(a), 44- 10-203(1)(c), 44-10-203(1)(k), 44- 10-203(2)(h), 44-10-501(1)(b), 44- 10-502(2), 44-10-503(1)(b), 44- 10-505(3), 44-10-601(1)(d), 44-10- 602(3), 44-10-603(1)(b), 44-10- 605(3), and 44-10-610(3)(a), C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-805 (G) | Regulated Marijuana Businesses: Inventory Tracking System | Revision | 44-10-201(1), 44-10-202(1)(a), 44- 10-203(1)(c), 44-10-203(1)(k), 44- 10-203(2)(h), 44-10-501(1)(b), 44- 10-502(2), 44-10-503(1)(b), 44- 10-505(3), 44-10-601(1)(d), 44-10- 602(3), 44-10-603(1)(b), 44-10- 605(3), and 44-10-610(3)(a), C.R. S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-810 (A) | Minimum Tracking Requirements | Revision | 44-10-201, 44-10-202(1)(a), 44- 10-202(1)(c), 44-10-203(2)(n), 44- 10-501(1)(b), 44-10-502(2), 44-10- 503(1)(b), 44-10-505(3), 44-10- 601(1)(d), 44-10-601(4), 44-10- 602(1), 44-10-602(6)(f), 44-10-603 (1)(b), and 44-10-605(3), C.R.S. | Added Genetic Material requirements to be entered into the Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-810 (C) | Minimum Tracking Requirements | Revision | 44-10-201, 44-10-202(1)(a), 44- 10-202(1)(c), 44-10-203(2)(n), 44- 10-501(1)(b), 44-10-502(2), 44-10- 503(1)(b), 44-10-505(3), 44-10- 601(1)(d), 44-10-601(4), 44-10- 602(1), 44-10-602(6)(f), 44-10-603 (1)(b), and 44-10-605(3), C.R.S. | Added Decontamination requirements to be entered into the Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-825 (C)(2) | Medical Marijuana Testing Facilities and Retail Marijuana Testing Facilities Specific Tracking Requirements | Revision | 44-10-202(1)(a), 44-10- 203(2)(d) (I), 44-10-504, and 44-10-604, C.R.S. | Clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-825 (C)(3) | Medical Marijuana Testing Facilities and Retail Marijuana Testing Facilities Specific Tracking Requirements | Revision | 44-10-202(1)(a), 44-10- 203(2)(d) (I), 44-10-504, and 44-10-604, C.R.S. | Added Transfers of Genetic Material to a Regulated Marijuana Cultivation Facility requirements to be entered into the Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-905 (A)(2) | Business Records Required | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), C.R.S. | Revised rule to shorten time requirement for Business Records required. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-905 (B)(7) | Business Records Required | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), C.R.S. | Adds reference to statute for clarity. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-905 (B)(16) | Business Records Required | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), C.R.S. | Revised rule to include Training Documentation and requirements to Business Records required. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-905 (B)(29) | Business Records Required | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), C.R.S. | Revised rule to include use-by date and cross reference for clarity. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-905 (B)(33) | Business Records Required | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), C.R.S. | Added Source Genetic Material Records requirements. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-920 (D) | Regulated Marijuana Business Reporting Requirements | Revision | 44-10-201(4), 44-10-204(1)(a), 44- 10-202(1)(c), 44-10-202(1)(a), 44- 10-204(1)(a), 44-10-203(1)(k), 44- 10-313(12), and 44-10-701(2)(a), C.R.S. | Added the requirement to report a fire on the Licensed Premises. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1005 (D) | Packaging and Labeling: Minimum Requirements Prior to Transfer to a Regulated Marijuana Business, except to a Regulated Marijuana Testing Facility | Revision | 44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44- 10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44- 10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S. | Added Genetic Material to Packaging and Labeling. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1005 (G)(1) | Packaging and Labeling: Minimum Requirements Prior to Transfer to a Regulated Marijuana Business, except to a Regulated Marijuana Testing Facility | Revision | 44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44- 10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44- 10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1015 (E) | Additional Labeling Requirements Prior to Transfer to a Patient or Consumer | Revision | 44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(d)(IV) (A)-(C), 44-10-203(2)(f), 44-10- 203(2)(w), 44-10-203(1)(a), 44- 10- 601(2)(a), 44-10-603(4)(a), and 44-10-603(8), C.R.S. | Added Decontaminated Product labeling requirements to rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1025 | Packaging and Labeling: Minimum Requirements for Test Batch Transfers to a Regulated Marijuana Testing Facility | Revision | 44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44- 10-203(1)(k), 44-10-203(3)(a)-(b), C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1025 (B)(1) | Packaging and Labeling: Minimum Requirements for Test Batch Transfers to a Regulated Marijuana Testing Facility | Revision | 44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44- 10-203(1)(k), 44-10-203(3)(a)-(b), C.R.S. | Clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1110 (C)(3) | Accelerator Shared Premises | Revision | 44-10-202(1)(c), 44-10-203(2)(aa), 44-10-310(2), and 44-10-311(2), C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 3-1115 (C)(3) | Accelerator Shared Premises | Revision | 44-10-202(1)(c), 44-10-203(2)(aa), 44-10-310(2), and 44-10-311(2), C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-105 | Regulated Marijuana Testing Program: Mandatory Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Clarified rule from Sample to Test Batch. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-110 (A) | Regulated Marijuana Testing Program: Sampling Procedures | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Clarified rule from Sample to Test Batch. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-110 (C) | Regulated Marijuana Testing Program: Sampling Procedures | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Added requirement for Designated Test Batch Collectors in the Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-110 (F) | Regulated Marijuana Testing Program: Sampling Procedures | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-115 (B)(1)(b) | Regulated Marijuana Testing Program: Sampling and Testing Program | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-115 (D) | Regulated Marijuana Testing Program: Sampling and Testing Program | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-115 (E)(2) | Regulated Marijuana Testing Program: Sampling and Testing Program | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. | Clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-120 (B)(1)(b) | Regulated Marijuana Testing Program: Contaminant Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Added requirements for Reduced Testing Allowances for microbial contaminants. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-120 (B)(4) | Regulated Marijuana Testing Program: Contaminant Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Clarified rule from Sample to Test Batch. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-120 (B)(6) | Regulated Marijuana Testing Program: Contaminant Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Added requirements for Reduced Testing Allowance Certification Fee. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-120 (C)(1) | Regulated Marijuana Testing Program: Contaminant Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-121 (D) | Regulated Marijuana Testing Program: Wet Whole Plant Contaminant Testing | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(3)(e), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | ||
1 CCR 212-3 Rule 4-125 (F)(5) | Regulated Marijuana Testing Program: Potency Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44- 10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44- 10-504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-135 (B) | Regulated Marijuana Testing Program: Contaminated Product and Failed Test Results and Procedures | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Added Wet Whole Plant to the rule and clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 4-135 | Regulated Marijuana Testing Program: Contaminated Product and Failed Test Results and Procedures | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1)(b), 44-10-504(2), 44-10- 601(4), 44-10-602(4), 44-10-603 (6), 44-10-604(1)(b), and 44-10- 604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). | Removed if possible from rule, now requires two new Test Batches after Decontamination. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-105 | Medical Marijuana Store: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(d)(I)-(VI), 44-10-313 (7), 44-10-313(4), 44-10-313(14), 44-10-401(2)(a)(I), 44-10-501, and 44-10-505, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-105 (L) | Medical Marijuana Store: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(d)(I)-(VI), 44-10-313 (7), 44-10-313(4), 44-10-313(14), 44-10-401(2)(a)(I), 44-10-501, and 44-10-505, C.R.S. | Aligns Medical Marijuana Store license privileges with revised Retail Marijuana Store and Accelerator Store license privileges as amended in HB 23-1279. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-200 Series | Medical Marijuana Cultivation Facility: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(II), and 44-10- 502, C.R.S. | Changes the title to Medical Marijuana Cultivation Facilities. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-205 (C)(3) | Medical Marijuana Cultivation Facility: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(II), 44-10-313, 44- 10-502, and 44-10-503, C.R.S. | Added ability to perform a Microbial Control Step to the rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-205 | Medical Marijuana Cultivation Facility: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(II), 44-10-313, 44- 10-502, and 44-10-503, C.R.S. | Added a rule to allow the transfer of Immature Plants, Medical Marijuana Seeds and Genetic Material by a Medical Marijuana Cultivation Facility. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-215 | Medical Marijuana Cultivation Facility: Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(i), 44-10-203(2)(d)(I) -(VI), 44-10-502(3), and 44-10-401 (2)(a)(II), C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-235 (A)(4) | Medical Marijuana Cultivation Facility: Ability to Change Designation of Regulated Marijuana | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-401(2)(a) (II), 44-10-502(9)(a)-(c), 44-10- 502(9.5), and 39-28.8-297, C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-300 Series | Medical Marijuana Products Manufacturers | Revision | 44-10-202(1)(c), 44-10-203(1)(k), and 44-10-503, C.R.S. | Changes the title to Medical Marijuana Products Manufacturer Facilities. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-305 | Medical Marijuana Products Manufacturers: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(d)(I)-(VI), 44-10-313 (14), and 44-10-503, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-335 (A)(4) | Medical Marijuana Products Manufacturer: Ability to Change Designation from Retail Marijuana Concentrate to Medical Marijuana Concentrate | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10- 503, 44-10-503(12)(a)-(b), and 39- 28.8-297, C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-405 | Medical Marijuana Testing Facilities: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10- 203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 313(14), 44-10-401(2)(a)(IV), 44- 10-501(6), 44-10-502(3), 44-10- 503(8), 44-10-504(1), and 44-10- 504(2), C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-410 | Medical Marijuana Testing Facilities: General Limitations or Prohibited Acts | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10- 203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 401(2)(a)(IV), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1), and 44-10-504(2), 44-10- 701, and 35-61-105.5, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-415 (C) | Medical Marijuana Testing Facilities: Certification Requirements | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10-203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 401(2)(a)(IV), and 44-10-504, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-420 (C) | Medical Marijuana Testing Facilities: Personnel | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10- 203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 401(2)(a)(IV), and 44-10-504, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-420 (F) | Medical Marijuana Testing Facilities: Personnel | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10- 203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 401(2)(a)(IV), and 44-10-504, C.R.S. | Removed requirement to hold at least a bachelor's degree for Laboratory Testing Analyst. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-430 | Medical Marijuana Testing Facilities: Analytical Processes | Revision | 44-10-203(2)(d), 44-10- 401(2)(a) (IV), and 44-10-504, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-435 (G) | Medical Marijuana Testing Facilities: Proficiency Testing | Revision | 44-10-203(2)(d), 44-10-401(2)(a) (IV), and 44-10-504, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-445 Basis and Purpose | Medical Marijuana Testing Facilities: Chain of Custody | Revision | 44-10-203(2)(d), 44-10-401(2)(a) (IV), and 44-10-504, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-455 | Notification of Medical Marijuana Business | Revision | 44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10-203(2) (f)(IV), 44-10-203(3)(d), 44-10- 203(3)(e), 44-10-313(8)(a), 44-10- 401(2)(a)(IV), 44-10-501(6), 44- 10-502(3), 44-10-503(8), 44-10- 504(1), and 44-10-504(2), C.R.S. | Adds clarity by including Rule cross references | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-705 (5.5) | Marijuana Research and Development Facilities: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(j), 44-10-203(1)(k), 44-10-203(2)(s), 44-10-401(1)(a) (VII), and 44-10-507, C.R.S. | Added Production of Semi-Synthetic Cannabinoids to the rule. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 5-725 | Marijuana Research and Development Facility: Testing | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-401(1)(a) (VII), and 44-10-507, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-105 | Retail Marijuana Store: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(dd), 44-10-313(14), 44-10-401(2)(b)(I), 44-10-601, and 44-10-605, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Adopted | January 8, 2023 | |
1 CCR 212-3 Rule 6-105 (K) | Retail Marijuana Store: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(dd), 44-10-313(14), 44-10-401(2)(b)(I), 44-10-601, and 44-10-605, C.R.S. | Implemented HB 23-1279 allowing for Sales over the internet and online payments. | MED Stakeholder List | Adopted | January 8, 2023 | |
1 CCR 212-3 Rule 6-110 | Retail Marijuana Store: General Limitations or Prohibited Acts | Revision | 44-10-202(1)(c), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(4)(b), 44-10-203(1)(k), 44-10-401(2)(b) (I), 44-10-701(1)(a), 44-10-701(3) (d) and (f), and 44-10-601, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsections 16(3)(a), 16(5) (a)(V) and 16(5)(a)(VIII). | Repealed Sales over internet to align with HB 23-1279. | MED Stakeholder List | Adopted | January 8, 2023 | |
1 CCR 212-3 Rule 6-205 | Retail Marijuana Cultivation Facility: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(r), 44-10-203(3)(c), 44-10-313(14), 44- 10-401(2)(b)(II), and 44-10- 602, C.R.S. | Implemented SB 23-271 allowing for a transfer to perform a Microbial Control Step and the allowance of the transfer of Immature Plants, Medical Marijuana Seeds and Genetic Material by a Retail Marijuana Cultivation Facility. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-230 | Retail Marijuana Cultivation Facility: Ability to Change Designation of Regulated Marijuana | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-401(2)(b) (II), 44-10-602(13)(a)-(c), 44-10- 602(13.5), and 39-28.8-299, C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-305 | Retail Marijuana Products manufacturer: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(i), 44-10-203(2)(y), 44-10-307(1)(j), 44- 10-313(14), 44-10-401(2)(b) (III), and 44-10-603, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-405 | Retail Marijuana Testing Facilities: License Privileges | Revision | 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(4), 44- 10-203(1)(a), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(c), 44- 10- 203(2)(d), 44-10-203(2)(h), 44-10-203(2)(y), 44-10-203(3)(c), 44-10-203(3)(d), 44-10-313(8)(a), 44-10- 313(14), 44-10-401(2)(b) (IV), 44-10-604, 35-61-104, and 35-61-105.5, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-405 (H) | Retail Marijuana Testing Facilities: License Privileges | Revision | 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(4), 44- 10-203(1)(a), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(c), 44- 10- 203(2)(d), 44-10-203(2)(h), 44-10-203(2)(y), 44-10-203(3)(c), 44-10-203(3)(d), 44-10-313(8)(a), 44-10- 313(14), 44-10-401(2)(b) (IV), 44-10-604, 35-61-104, and 35-61-105.5, C.R.S. | Implemented SB 23-271 allowing for the transfer of Immature Plants, Regulated Marijuana Seeds and Genetic Material by a Retail Marijuana Testing Facilities. In addition, added a rule regarding conflict of interest with Retail Marijuana Testing Facility. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-410 | Retail Marijuana Testing Facilities: General Limitations or Prohibited Acts | Revision | 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(c), 44-10-203(2)(d), 44- 10-202(4), 44-10-203(2)(h), 44-10-203(2)(y), 44-10-203(3)(c), 44-10-203(2)(d), 44-10-401(2)(b) (IV), 44- 10-604, 44-10-701, 35- 61-104, and 35-61-105.5, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-415 | Retail Marijuana Testing Facilities: Certification Requirements | Revision | 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(4), 44- 10-203(1)(a), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(c), 44- 10-203(2)(d), 44-10-203(2)(h), 44- 10-203(2)(y), 44-10-203(3)(c), 44- 10-203(3)(d), 44-10-401(2)(b)(IV), and 44-10-604, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-420 (F) | Retail Marijuana Testing Facilities: Personnel | Revision | 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(4), 44- 10-203(1)(c), 44-10-203(1)(k), 44- 10-203(2)(c), 44-10-203(2)(d), 44- 10- 203(3)(c), 44-10-203(3)(d), 44-10-401(2)(b)(IV), 44-10-604, C.R.S. | Removed requirement to hold at least a bachelor's degree for Laboratory Testing Analyst. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-425 (A)(22) | Retail Marijuana Testing Facilities: Standard Operating Procedure Manual | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-202(4), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-430 | Retail Marijuana Testing Facilities: Analytical Processes | Revision | 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-202(4), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-435 | Retail Marijuana Testing Facilities: Proficiency Testing | Revision | 44-10-202(4), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(d), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-440 | Retail Marijuana Testing Facilities: Quality Assurance and Quality Control | Revision | 44-10-202(4), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(d), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Clarified rule by adding Increments to Sample. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-445 Basis and Purpose | Retail Marijuana Testing Facilities: Chain of Custody | Revision | 44-10-202(4), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(d), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Clarified Basis and Purpose from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-455 | Notification of Retail Marijuana Business | Revision | 44-10-202(4), 44-10-203(1)(c), 44- 10-203(1)(k), 44-10-203(2)(d), 44- 10-401(2)(b)(IV), and 44-10-604, C.R.S. | Adds clarity by including Rule cross references | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-705 | Accelerator Cultivator: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(r), 44-10-203(2)(aa), 44-10-203(3)(c), 44- 10-401(2)(b)(VII), 44-10-602, and 44-10-607 C.R.S. | Implemented SB 23-271 allowing for the transfer of and ability to obtain Immature Plants, Regulated Marijuana Seeds and Genetic Material by a Accelerator Cultivator and allowance to perform a Microbial Control Step. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-705 (E) | Accelerator Cultivator: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(r), 44-10-203(2)(aa), 44-10-203(3)(c), 44- 10-401(2)(b)(VII), 44-10-602, and 44-10-607 C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-730 | Accelerator Cultivator: Ability to Change Designation of Regulated Marijuana | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-401(2)(b) (II), 44-10-602(13)(a)-(c), 44-10- 602(13.5), 44-10-607, and 39- 28.8-301, C.R.S. | Replaced RFID with Inventory Tracking System. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-805 | Accelerator Manufacturer: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(i), 44-10-203(2)(y), 44-10-203(2)(aa), 44- 10-307(1)(j), 44-10-401(2)(b) (VIII), 44-10-603 and 44-10-608, C.R.S. | Clarified rule from Sample to Test Batches and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-905 (H) | Licensed Hospitality Businesses: General Provisions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Replaced supervised with reasonably monitored. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-905 (I) | Licensed Hospitality Businesses: General Provisions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Added the Transfer to Consumption By Intoxicated Patrons Prohibited. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-905 (Q) | Licensed Hospitality Businesses: General Provisions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Added a requirement to provide information on safe transportation in a Licensee's SOP. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-925 (B) | Retail Marijuana Hospitality and Sales Businesses: Additional License Privileges and Restrictions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Added requirement that at least a portion of the Transferred Retail Marijuana would need to be consumed on site. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-925 (G) | Retail Marijuana Hospitality and Sales Businesses: Additional License Privileges and Restrictions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Increased Quantity Limitations on Sales in a single day, added a rule for the allowance of multiple transfers on one transaction, and sales limits per consumer. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-925 (H) | Retail Marijuana Hospitality and Sales Businesses: Additional License Privileges and Restrictions | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Clarified rule to allow for the sales limitations and provisions for sharing Retail Marijuana. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-926 | Retail Marijuana Hospitality and Sales Businesses: Spa Businesses | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Added a rule allowing for a Hospitality Business to operate a Regulated Marijuana Spa Business. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-930 (B) | Retail Marijuana Hospitality and Sales Businesses: General Limitations and Prohibited Acts | Revision | 44-10-202(1), 44-10-203(2)(ff), 44-10-305(2)(b), 44-10-609, and 44-10-610, C.R.S. | Removed the requirement for a consumer to consume in a Restricted Access Area and the requirement for an Application to operate as a Spa Business. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 6-1105 | Accelerator Store: License Privileges | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(aa), 44-10-203(2) (dd), 44-10-401(2)(b)(I), 44-10- 601, 44-10-605, and 44-10-611, C.R.S. | Implemented HB 23-1279 allowing for Sales over the internet and online payments, clarified rule from Sample to Test Batches, and removed references to Industrial regarding Hemp Products. | MED Stakeholder List | Adopted | August 8, 2023 | |
1 CCR 212-3 Rule 6-1110 (E) | Accelerator Store: General Limitations or Prohibited Acts | Revision | 44-10-202(1)(c), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(4)(b), 44-10-203(1)(k), 44-10-203(2) (aa), 44-10-401(2)(b)(I), 44-10- 601, 44- 10-611, 44-10-701(1)(a), and 44-10-701(3)(d) and (f), C.R. S. Authority also exists in the Colorado Constitution at Article XVIII, Subsections 16(3)(a), 16(5) (a)(V) and 16(5)(a)(VIII). | Repealed Sales over internet to align with HB 23-1279. | MED Stakeholder List | Adopted | August 8, 2023 | |
1 CCR 212-3 Rule 8-110 | Requirement for Inspections and Investigations, Searches, Administrative Holds, Voluntary Surrenders and Such Additional Activities as May Become Necessary from Time to Time | Revision | 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(f), 44-10-202(1)(g), 44-10-203(1)(k), and 44-10-902, C.R.S. | Implemented HB 23-1021 allowing for Embargo of Regulated Marijuana and a Notice of and requirements for an Administrative Hold. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 8-220 | Administrative Hearings | Revision | 44-10-202(1)(c), 44-10-202(1)(d), 44-10-203(1)(k), 44-10-203(2)(a), 44-10-203(2)(l), 44-10-204(1)(a), 44-10-701, 44-10-901, 24-4-104, and 24-4-105, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(I). | Implemented HB 23-1021 allowing for a Notice of Destruction and rules to request a hearing. | MED Stakeholder List | Ongoing | January 8, 2023 | |
1 CCR 212-3 Rule 8-235 | Penalties | Revision | 44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-701, and 44-10-901(3)(b), C.R.S. | Clarified rule from Sample to Test Batches. | MED Stakeholder List | Ongoing | January 8, 2023 |